Chronic Inflammation & Longevity: How Inflammaging Accelerates Every Disease of Aging

Chronic Inflammation & Longevity: How “Inflammaging” Accelerates Every Disease of Aging

In 2000, gerontologists Claudio Franceschi and Massimo Bonafè coined the term “inflammaging” to describe a phenomenon they’d observed across decades of aging research: the hallmark of biological aging is not just cellular senescence or telomere shortening, but a chronic, smoldering, low-grade activation of the innate immune system that persists for decades before clinical disease emerges.

The concept has been validated many times over. We now know that elevated hsCRP, IL-6, and TNF-alpha are not just markers of existing disease — they predict future disease in otherwise healthy individuals. A 45-year-old with elevated hsCRP and no cardiovascular symptoms has a measurably different 10-year cardiovascular risk profile than a 45-year-old with identical cholesterol and blood pressure but normal inflammatory markers. Inflammation is not a consequence of aging. It is a cause of it.

This guide explains the biology, the measurable biomarkers, and the specific diet, exercise, sleep, and supplementation interventions with the strongest anti-inflammatory evidence — so you can assess and systematically lower your inflammaging burden.

What Is Inflammaging? Acute vs. Chronic Inflammation

Acute inflammation is the immune system’s precisely orchestrated response to injury or infection: blood vessels dilate, neutrophils and macrophages flood the site, pathogens are neutralized, tissue is repaired, and the response resolves within days. This process is essential for survival and is not harmful.

Chronic low-grade inflammation — inflammaging — is categorically different. It is characterized by a persistent, systemic elevation of pro-inflammatory cytokines (IL-1β, IL-6, IL-18, TNF-alpha) at 2–4× above healthy baseline, without a resolving acute trigger. The immune system is perpetually partially activated — not at the level required to produce symptoms, but at a level sufficient to damage endothelial cells, oxidize LDL particles, promote insulin receptor downregulation, accelerate neurodegeneration, and create a permissive environment for oncogenesis over decades.

The NF-κB Master Switch

The central molecular driver of chronic inflammation is nuclear factor kappa-B (NF-κB) — a transcription factor that, when chronically activated, upregulates the expression of hundreds of pro-inflammatory genes including COX-2, iNOS, and the cytokines listed above. NF-κB is activated by visceral fat (via adipokines), advanced glycation end-products (AGEs) from dietary ultra-processed foods and elevated blood glucose, gut dysbiosis (via LPS translocation across a permeable gut barrier), sleep deprivation, psychological stress (via cortisol pathway crosstalk), and environmental toxins. Most anti-inflammatory interventions work, in part, by suppressing NF-κB activation through one or more of these pathways.

The 8 Primary Drivers of Chronic Inflammation

1. Visceral adiposity. Visceral fat is not metabolically inert. It secretes leptin, resistin, and TNF-alpha at rates 3–4× higher than subcutaneous fat, and adipose-derived IL-6 accounts for approximately 30% of circulating IL-6 in obese individuals. Every centimeter of increased waist circumference above the threshold (40 inches men, 35 inches women) correlates with measurable increases in hsCRP.

2. Ultra-processed food and dietary AGEs. Ultra-processed foods (UPFs) — refined oils high in omega-6 linoleic acid, refined carbohydrates, added sugars, and emulsifiers — are among the most potent dietary drivers of NF-κB activation. The NOVA classification system groups foods into 4 processing categories; cohort data consistently show that each 10% increase in UPF caloric share is associated with a 12–16% increase in inflammatory biomarker burden and a 14% increase in all-cause mortality.

3. Gut dysbiosis and intestinal permeability. A disrupted gut microbiome — reduced diversity, overgrowth of gram-negative bacteria, low short-chain fatty acid production — increases intestinal permeability (“leaky gut”). Lipopolysaccharide (LPS) from gram-negative bacterial cell walls translocates across a permeable gut epithelium into systemic circulation, activating TLR4 receptors on macrophages and triggering a low-grade inflammatory cascade called “metabolic endotoxemia.” Low-fiber diets, antibiotic overuse, and UPFs all promote this mechanism.

4. Sleep deprivation. A single night of poor sleep raises IL-6 by 40–60% and CRP by 25–40%, per a 2019 meta-analysis by Irwin et al. Chronic sleep restriction below 6 hours per night elevates baseline inflammatory markers persistently. Sleep optimization is one of the fastest-acting anti-inflammatory interventions — measurable reductions in hsCRP typically appear within 2–4 weeks of improving sleep quality and duration.

5. Chronic psychological stress. Cortisol is acutely anti-inflammatory — but chronically elevated cortisol causes glucocorticoid receptor resistance in immune cells, paradoxically increasing inflammatory cytokine production. Chronic stress also elevates sympathetic tone, reducing heart rate variability and activating NF-κB via catecholamine-receptor signaling.

6. Sedentary behavior. Physical inactivity — independent of obesity — is associated with elevated IL-6, CRP, and TNF-alpha. Contracting muscle releases anti-inflammatory myokines (including IL-6 in its exercise-derived, anti-inflammatory context) that counteract adipose-derived pro-inflammatory signaling. Sitting time above 8 hours per day is independently associated with elevated inflammatory markers even in physically active individuals who exercise regularly — underscoring the importance of movement throughout the day, not just exercise sessions.

7. Omega-6:omega-3 imbalance. The human body evolved on a dietary omega-6:omega-3 ratio of approximately 4:1. The modern Western diet delivers a ratio of 15:1 to 25:1 — driven by seed oil proliferation (corn, soybean, sunflower oil) and reduced fatty fish consumption. Excess omega-6 linoleic acid is the precursor to arachidonic acid and pro-inflammatory eicosanoids (PGE2, LTB4). Restoring the ratio to below 4:1 through omega-3 supplementation and dietary change reliably reduces hsCRP, IL-6, and TNF-alpha.

8. Cellular senescence accumulation. Senescent cells — cells that have permanently exited the cell cycle due to DNA damage, oxidative stress, or telomere shortening — secrete a pro-inflammatory cocktail called the senescence-associated secretory phenotype (SASP): IL-1α, IL-6, IL-8, MMP-3, and CXCL1. SASP from accumulating senescent cells is a major driver of inflammaging in older adults, and is currently the primary therapeutic target for senolytic drug development (dasatinib + quercetin, fisetin, navitoclax).

How to Measure Inflammation: Key Lab Biomarkers

Routine inflammatory assessment requires more than a standard CBC. Here are the panels I use in practice for comprehensive inflammaging assessment:

High-Sensitivity CRP (hsCRP)

The primary clinical inflammaging biomarker. hsCRP below 1.0 mg/L is low cardiovascular risk; 1.0–3.0 mg/L is intermediate; above 3.0 mg/L is high. Above 10 mg/L typically indicates acute infection or injury and should be retested after resolution. The JUPITER trial (Ridker et al., NEJM 2008) demonstrated that statin therapy in patients with low LDL but elevated hsCRP above 2 mg/L reduced cardiovascular events by 44% — showing that treating inflammation alone, independent of cholesterol, confers major benefit. I target hsCRP below 1.0 mg/L in all longevity patients.

Interleukin-6 (IL-6)

IL-6 is more sensitive than hsCRP for early inflammaging detection. Normal range is below 7 pg/mL; I prefer below 3 pg/mL in longevity patients. IL-6 is the primary hepatic stimulus for CRP production (CRP is a downstream marker of IL-6), so elevated IL-6 with normal CRP can indicate early inflammaging before it reaches the threshold for CRP elevation. IL-6 also directly impairs insulin receptor signaling, explaining the metabolic-inflammatory link.

Homocysteine, Fibrinogen, and Oxidized LDL

Homocysteine above 12 µmol/L is an independent cardiovascular risk factor driven by B-vitamin insufficiency (B6, B12, folate) and reflects endothelial oxidative stress. Fibrinogen above 400 mg/dL reflects a pro-thrombotic, pro-inflammatory state. Oxidized LDL is a more specific cardiovascular risk marker than standard LDL — it’s the oxidized form that is taken up by macrophages to form foam cells in atherosclerotic plaques. A comprehensive inflammaging panel includes all of these alongside hsCRP and IL-6 for a complete picture of vascular inflammation.

The Anti-Inflammatory Diet: What the Evidence Shows

Mediterranean Diet: The Gold Standard

The PREDIMED trial (Estruch et al., NEJM 2013) — 7,447 participants, 5 years follow-up — found that Mediterranean diet supplemented with extra-virgin olive oil (EVOO) or nuts reduced major cardiovascular events by 30% compared to a low-fat control diet. The anti-inflammatory mechanism involves: polyphenols in EVOO (oleocanthal, oleuropein) that inhibit COX-1 and COX-2 similarly to ibuprofen at typical dietary doses; flavonoids from vegetables and fruits that suppress NF-κB; high fiber intake that feeds butyrate-producing gut bacteria (Faecalibacterium prausnitzii, Roseburia), reducing intestinal permeability; and omega-3 from fatty fish that shifts prostaglandin synthesis toward anti-inflammatory resolvins and protectins.

Ultra-Processed Food Elimination

A 2019 Cell study by Sonnenburg et al. (comparing high-fiber vs. high-fermented-food diets) and multiple cohort analyses now establish that UPF elimination is one of the most impactful single dietary interventions for reducing inflammatory burden. The mechanisms are multiple: elimination of omega-6 seed oils reduces arachidonic acid availability; elimination of refined carbohydrates reduces AGE formation and glucose-driven NF-κB activation; elimination of emulsifiers (carboxymethylcellulose, polysorbate-80) restores gut microbiome diversity and reduces intestinal permeability. A practical threshold: aim for fewer than 20% of total calories from NOVA Group 4 (ultra-processed) foods.

Fermented Foods and Gut Barrier Integrity

Sonnenburg’s 2021 Cell study found that a 10-week high-fermented-food diet (yogurt, kefir, kimchi, kombucha, fermented vegetables) increased gut microbiome diversity and reduced 19 inflammatory proteins including IL-12, IL-17, and CXCL10 — significantly more than a high-fiber diet in the same cohort. This is a remarkable finding: adding fermented foods may reduce inflammatory burden faster than eliminating pro-inflammatory foods. I recommend 2–3 servings of fermented foods daily as a cornerstone of the anti-inflammatory dietary protocol.

Lifestyle Interventions: Exercise, Sleep & Stress Reduction

Exercise as Anti-Inflammatory Medicine

Both aerobic exercise and resistance training have independent, additive anti-inflammatory effects. Zone 2 aerobic training (at lactate threshold — 60–70% max heart rate) drives mitochondrial biogenesis, reduces visceral fat mass (the primary inflammatory adipose depot), and enhances insulin sensitivity — all of which reduce upstream NF-κB activation. Resistance training releases myokines with direct anti-inflammatory activity and builds the lean mass that improves metabolic health. A 2017 meta-analysis by Fedewa et al. found that exercise interventions reduce hsCRP by an average of 0.31–0.58 mg/L, with the largest reductions in patients with baseline hsCRP above 3.0 mg/L. The minimum effective anti-inflammatory dose: 150 minutes per week of moderate-intensity exercise or 75 minutes of vigorous exercise.

Sleep: The Fastest Anti-Inflammatory Reset

Sleep is perhaps the fastest-acting anti-inflammatory intervention available. During slow-wave sleep (SWS), the glymphatic system clears inflammatory metabolites from the brain; growth hormone pulses drive cellular repair; and cortisol falls to its nadir — allowing the anti-inflammatory parasympathetic nervous system to dominate. Irwin et al.’s meta-analysis confirmed that short sleep duration raises IL-6 and TNF-alpha significantly. Conversely, patients who improve sleep duration from 5–6 to 7–9 hours show measurable reductions in hsCRP within 4 weeks. Sleep optimization strategies — including consistent sleep timing, cool room temperature (65–68°F), darkness, and minimizing blue light exposure — should be the first anti-inflammatory intervention recommended.

Evidence-Based Supplementation for Chronic Inflammation

Omega-3 EPA/DHA: The Most Validated Anti-Inflammatory Supplement

EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are the most evidence-supported anti-inflammatory supplements. At doses of 2–4 g/day of combined EPA+DHA, they shift prostaglandin synthesis from pro-inflammatory PGE2 (from arachidonic acid) to anti-inflammatory resolvins and protectins. The REDUCE-IT trial found that icosapentaenoic acid (EPA only, 4 g/day as Vascepa) reduced major cardiovascular events by 25% in patients with elevated triglycerides despite statin therapy. I recommend 2–4 g/day of high-quality, third-party-tested fish oil (look for IFOS certification) targeting an omega-3 index above 8%.

Vitamin D3: Immune Modulator and NF-κB Suppressor

Vitamin D3 (cholecalciferol) acts as a steroid hormone across virtually every immune cell type, downregulating NF-κB and upregulating anti-inflammatory IL-10. Deficiency (25-OH-D below 30 ng/mL) is extraordinarily common — estimated at 40–70% of the U.S. adult population — and is associated with elevated hsCRP, impaired T-regulatory cell function, and increased autoimmune disease risk. I target 50–70 ng/mL in longevity patients, typically requiring 5,000–10,000 IU D3 daily with K2 (100–200 mcg MK-7) for calcium trafficking. Serum 25-OH-D should be checked at baseline and 90 days after initiating supplementation.

Magnesium: The Cofactor for 300 Enzymatic Reactions

Magnesium deficiency — present in approximately 45% of U.S. adults — is associated with elevated CRP and NF-κB activation. Magnesium acts as a natural calcium channel blocker and NMDA receptor antagonist, reducing excitatory inflammatory signaling. A 2018 meta-analysis found that magnesium supplementation at 300–400 mg/day significantly reduces CRP in patients with magnesium insufficiency. I prefer magnesium glycinate or malate (better absorbed, less GI disturbance than oxide or citrate) at 400 mg/day taken in the evening — it also improves sleep quality by activating GABA receptors, providing a dual anti-inflammatory benefit.

Frequently Asked Questions

What is a “normal” hsCRP level?

The American Heart Association risk stratification defines hsCRP below 1.0 mg/L as low cardiovascular risk, 1.0–3.0 mg/L as intermediate, and above 3.0 mg/L as high risk. For longevity optimization, I target below 0.7 mg/L — consistent with the hsCRP range of the least inflammatory tertile in centenarian studies. Values above 10 mg/L almost always indicate acute infection or injury and should be rechecked after the acute event resolves before drawing longevity conclusions. Note that testing hsCRP while you have an acute illness, dental infection, or recent injury will produce falsely elevated results.

Can I lower my CRP with diet alone?

Yes — dietary change is one of the most potent CRP-lowering interventions available. The PREDIMED trial demonstrated that Mediterranean diet reduced hsCRP significantly within 3 months. Reducing ultra-processed foods, eliminating seed oils, increasing oily fish (2–3 servings/week), adding 2–4 tablespoons of extra-virgin olive oil daily, and consuming 30+ different plant foods per week are the highest-yield dietary changes. In patients with baseline hsCRP of 3–6 mg/L, I typically see 30–50% reductions within 8–12 weeks of comprehensive dietary change combined with omega-3 supplementation — no medications required.

Does stress really increase inflammation?

Yes — the evidence is extensive and mechanistically well-characterized. The cytokine hypothesis of depression (Slavich and Irwin, Psychological Bulletin, 2014) established that chronic psychological stress activates the same NF-κB and pro-inflammatory cytokine pathways as physical injury. Glucocorticoid receptor resistance — where immune cells no longer respond normally to cortisol’s anti-inflammatory signal — is the key mechanism by which chronic stress becomes chronically inflammatory. Mind-body practices with documented anti-inflammatory effects include mindfulness meditation (reduces NF-κB activation and IL-6), yoga (reduces cortisol and inflammatory markers), and HRV biofeedback (increases vagal tone, which suppresses inflammatory cytokine production via the cholinergic anti-inflammatory pathway).

Are anti-inflammatory foods enough, or do I need supplements?

Diet-first is always the right approach — but certain supplementation provides meaningful anti-inflammatory benefit that is difficult to achieve through food alone. It’s virtually impossible to consume therapeutic EPA+DHA doses (2–4 g/day) through food without eating oily fish 4–5× per week. Vitamin D3 at 5,000–10,000 IU cannot be replicated through diet (the highest dietary source, cod liver oil, provides ~1,300 IU per tablespoon). Magnesium at therapeutic doses requires consuming large amounts of magnesium-rich foods daily — achievable in theory but rarely achieved in practice. I view high-quality supplements as filling the gaps that even an excellent diet leaves — not replacing dietary change, but completing it.

Is there a single best anti-inflammatory drug?

Low-dose aspirin (81 mg/day) had a long run as a preventive anti-inflammatory tool, but 2018 ASCEND and ARRIVE trials showed that primary prevention aspirin increases GI bleeding risk without significant cardiovascular benefit in low-to-intermediate risk patients. Statins have direct anti-inflammatory effects independent of cholesterol lowering (the pleiotropic effects) — the JUPITER trial showed rosuvastatin reduced hsCRP by 37% and cardiovascular events by 44% in patients with elevated CRP. Metformin at 500–1,000 mg/day has emerging evidence as an NF-κB inhibitor and AMPK activator with anti-inflammatory and potential anti-senescent effects. That said, the lifestyle interventions above produce anti-inflammatory effects equivalent to or exceeding pharmacological options without the side effect profile — and should always be optimized before adding medications for inflammation management.

Bottom Line

Inflammaging — chronic low-grade inflammation — is the upstream driver of virtually every disease that kills us prematurely. It is measurable (hsCRP, IL-6, homocysteine, fibrinogen), modifiable, and responsive to interventions available to everyone: Mediterranean-pattern diet with abundant polyphenols and omega-3, daily fermented foods, elimination of ultra-processed foods, 150+ minutes per week of exercise, 7–9 hours of quality sleep, evidence-based supplementation (omega-3 2–4 g/day, vitamin D3 to 50–70 ng/mL, magnesium 400 mg/day), and stress management.

The ROI on reducing inflammation is extraordinary. Every percentage-point reduction in hsCRP carries independent prognostic significance for cardiovascular, cognitive, and metabolic outcomes. And unlike most pharmaceutical interventions, anti-inflammatory lifestyle change has positive side effects: lower body weight, better metabolic markers, improved sleep, and higher HRV — all of which further reduce inflammation in a virtuous cycle.

If you’d like a comprehensive inflammaging assessment — including hsCRP, IL-6, homocysteine, oxidized LDL, and a personalized anti-inflammatory protocol — I’d be glad to review your panel and build a targeted intervention plan. Schedule a functional medicine consultation.

Sources

• Ridker PM, Everett BM, Thuren T, et al. “Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.” N Engl J Med. 2017. PMID: 28845751
• Estruch R, Ros E, Salas-Salvadó J, et al. “Primary Prevention of Cardiovascular Disease with a Mediterranean Diet.” N Engl J Med. 2013. PMID: 23432189
• Ridker PM, Danielson E, Fonseca FA, et al. “Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein.” N Engl J Med. 2008. PMID: 18997196
• Wastyk HC, Fragiadakis GK, Perelman D, et al. “Gut-microbiota-targeted diets modulate human immune status.” Cell. 2021. PMID: 34256014
• Irwin MR, Olmstead R, Carroll JE. “Sleep Disturbance, Sleep Duration, and Inflammation.” Biol Psychiatry. 2016. PMID: 26140821
• Calder PC. “Omega-3 fatty acids and inflammatory processes: from molecules to man.” Biochem Soc Trans. 2017. PMID: 28408469

Dive Deeper

• Inflammaging: How Chronic Inflammation Drives Every Major Age-Related Disease
• Chronic Inflammation: The Silent Driver of Heart Disease, Diabetes, and Alzheimer’s
• Chronic Pain and Inflammation: The Root Cause Protocol That Works Without NSAIDs
• Inflammation Biomarkers: Comprehensive Testing Panel Beyond Standard CRP
• Anti-Inflammatory Diet: The Evidence-Based Protocol to Lower CRP 30-40%